Volume 21, Number 3—March 2015
Reemergence of Murine Typhus in Galveston, Texas, USA, 2013
Views: Views equals page views plus PDF downloadsMetric Details
Highlight and copy the desired format.
|EID||Blanton LS, Vohra RF, Bouyer DH, Walker D. Reemergence of Murine Typhus in Galveston, Texas, USA, 2013. Emerg Infect Dis. 2015;21(3):484-486. https://dx.doi.org/10.3201/eid2103.140716|
|AMA||Blanton LS, Vohra RF, Bouyer DH, et al. Reemergence of Murine Typhus in Galveston, Texas, USA, 2013. Emerging Infectious Diseases. 2015;21(3):484-486. doi:10.3201/eid2103.140716.|
|APA||Blanton, L. S., Vohra, R. F., Bouyer, D. H., & Walker, D. (2015). Reemergence of Murine Typhus in Galveston, Texas, USA, 2013. Emerging Infectious Diseases, 21(3), 484-486. https://dx.doi.org/10.3201/eid2103.140716.|
Twelve patients with murine typhus were identified in Galveston, Texas, USA, in 2013. An isolate from 1 patient was confirmed to be Rickettsia typhi. Reemergence of murine typhus in Galveston emphasizes the importance of vector control and awareness of this disease by physicians and public health officials.
Murine typhus, caused by Rickettsia typhi, is typically transmitted to humans by Xenopsylla cheopis, a flea that infests rats. The disease is endemic to tropical and subtropical seaboard regions throughout the world (1). Before the introduction of DDT in 1946 as a means of controlling rat ectoparasites, murine typhus was a frequent cause of illness in Galveston, Texas, USA (2). After nearly 8 decades during which no cases were identified in this city (although unreported cases might have occurred), murine typhus was diagnosed in 2 Galveston residents in April (3) and October 2012 (L.S. Blanton, unpub. data). These cases prompted this study of murine typhus as a cause of undifferentiated febrile illness in residents of Galveston County who sought care at the University of Texas Medical Branch in Galveston.
Physicians who were aware of the study alerted our team of investigators to patients >18 years of age who had reported fever during February–December 2013. Alternative syndromes that warranted exclusion included skin and soft tissue infections, urinary tract infections, cavitary or lobar pneumonia, and pyogenic intraabdominal processes (e.g., abscesses, appendicitis, cholecystitis, and diverticulitis). We obtained informed consent, medical history, and physical examination to record symptoms, signs, and laboratory data from each patient. We collected blood for use in real-time PCR, shell vial culture, and immunofluorescence assay (IFA) for the diagnosis of murine typhus (4–6). The conjugate used in IFA assays was Alexa Fluor 488 goat anti-human IgG (γ-chain–specific) at a dilution of 1:400 (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). We made extensive attempts to collect blood from enrollees for convalescent IFA testing. Further PCR analysis to amplify portions of the 17-kDa antigen, citrate synthase, and outer membrane protein B (ompB) genes were performed on DNA from a cell culture isolate (7–9). Amplicons were cloned and sequenced (4).
A confirmed case of murine typhus was defined as having compatible signs and symptoms and seroconversion (diagnostic cutoff of 1:64) or a 4-fold increase in IgG titer against R. typhi from acute- and convalescent-phase serum samples; PCR detection of rickettsial DNA within acute-phase blood; or isolation of R. typhi from blood. A probable case was defined as having a single IgG titer of >1:256 during acute illness.
In addition to identifying acutely ill patients, we sought to determine the local prevalence of those who had R. typhi reactive antibodies. We repurposed serum samples collected from 500 Galveston residents; the samples were scheduled to be discarded after being used for routine clinical testing from outpatient clinics during the summer and fall of 2013. We screened for the presence of R. typhi IgG at a titer of 1:128 by IFA as described above. Endpoint titers were established in reactive samples. We performed IFA against spotted fever antigens (R. rickettsii) and Western blot analysis using R. typhi and R. rickettsii antigens to confirm the specificity of samples reactive to R. typhi as previously described (6,10). The University of Texas Medical Branch institutional review board approved these studies.
Eighteen patients who met study criteria were enrolled. Of these, 10 were determined to have murine typhus (7 confirmed and 3 probable) (Table 1). In addition to those identified prospectively, 2 probable cases were identified retrospectively. Serologic testing was the primary diagnostic method (6 of 7 confirmed cases). One case was confirmed by isolation of R. typhi from blood. This patient was an alcoholic man, 48 years of age, who sought care 4 days after the onset of fever, chills, and myalgias. Sequences of portions of the citrate synthase (GenBank accession no. KJ648945) and ompB (accession no. KJ648946) genes of this isolate revealed 100% homology to R. typhi Wilmington strain, and the sequence of the 17-kDa antigen gene (accession no. KJ648944) revealed 1 base pair difference. Real-time PCR screening of DNA extracted from whole blood demonstrated the presence of rickettsial DNA in the patient from whom the R. typhi isolate was obtained.
In addition to fever, the 12 patients, all reported headache, 7 (58%) had chills, 6 (50%) reported myalgias, 6 (50%) had rashes, and 9 (75%) had elevated hepatic transaminases (75%). Seven (58%) were hospitalized, and 2 (17%) were admitted to the intensive care unit. Except for 1 of the retrospectively identified cases, all patients were treated empirically for murine typhus (Table 1). Eleven (92%) were treated with either doxycycline or minocycline; minocycline was prescribed for some because of a national shortage of oral doxycycline. All patients had subsequent resolution of illness with no obvious difference in recovery between the 2 drugs. One patient (identified retrospectively) was treated with levofloxacin and reported slow resolution of her symptoms.
The 500 serum samples screened by IFA represent ≈1% of Galveston’s population (48,733 by the 2013 census [http://quickfacts.census.gov/qfd/states/48/4828068.html; cited 2014 Dec 27]). The mean age of patients whose samples were tested was 61.5 years. IFA and Western blot testing showed 8 (1.6%) samples to be reactive, which supported typhus group specificity (Table 2). Of those seroreactive, the mean age was 60.9 years, and 5 (62.5%) were women. The geometric mean reciprocal titer was 181.
Galveston is a small city on a barrier island off the upper Texas coast, along the Gulf of Mexico. As with other port cities where rat population numbers are high, the incidence of murine typhus in this city was historically high. However, in 1946, as part of an ectoparasite eradication program, the insecticide DDT was applied to common rat paths; subsequently, the number of ectoparasites spread by rats in human habitats was reduced. As a result, the incidence of murine typhus in Galveston decreased dramatically (2) and continued to decline through subsequent decades (11). This study describes what is probably the reemergence of murine typhus in this area.
The patients in this study exhibited typical signs and symptoms consistent with murine typhus (12). Although we cannot exclude the possibility of a different fleaborne rickettsia (i.e., R. felis) infecting some patients, the single rickettsial isolate identified supports R. typhi as a causative agent. The seroprevalence supports the occurrence of additional undiagnosed cases. Based solely on the titers of these reactive serum samples, it is not possible to elucidate recent versus distant infections. Sporadic cases may have gone undiagnosed.
Dynamic shifts in the epidemiology and transmission of murine typhus are not unprecedented. Although the rat-to-rat cycle of transmission by fleas is often referred to as an urban cycle, the rural South experienced high rates of murine typhus in the 1940s as a result of a proliferation of rats after a change in crop production from cotton to peanuts, because rats were attracted to the peanuts as a source of food (13). In southern California, opossums infested with R. typhi– and R. felis–infected cat fleas (C. felis) have been associated with a shift of fleaborne rickettsioses from the urban center of Los Angles to suburban areas (14). This suburban cycle of transmission involving C. felis plays a recognized role in Corpus Christi, Texas, a coastal city ≈220 miles southwest of Galveston (1). Additionally, this cycle has been suspected in a recent outbreak of murine typhus in the central Texas city of Austin (15).
The recent recognition of murine typhus in Galveston may reflect the reemergence of R. typhi in rats; it may also reflect a cycle involving opossums and cats. Additionally, R. felis may play a role as a serologically cross-reacting culprit of illness. Further study is required to better understand the ecology and epidemiology of murine typhus as it reemerges in Galveston. Physicians and public health officials should be aware of this reemerging threat. Furthermore, vector control is of utmost importance.
Dr. Blanton is an infectious disease physician at the University of Texas Medical Branch. His research interests are in the study of rickettsial diseases.
We thank the faculty and staff of the University of Texas Medical Branch who helped identify patients with murine typhus. We also thank Anthony Okorodudu and Tho Nguyen for their help in the clinical laboratory.
This work was supported by the Carmage and Martha Walls Distinguished University Chair in Tropical Diseases Endowment.
- Azad AF, Radulovic S, Higgins JA, Noden BH, Troyer JM. Flea-borne rickettsioses: ecologic considerations. Emerg Infect Dis. 1997;3:319–27.
- Strandtmann RW, Eben DJ. A survey of typhus in rats and rat ectoparasites in Galveston, Texas. Tex Rep Biol Med. 1953;11:144–51 .
- Basra G, Berman MA, Blanton LS. Murine typhus: an important consideration for the nonspecific febrile illness. Case Rep Med. 2012;2012:134601 [cited 2014 Dec 12]. http://www.pubfacts.com/detail/23326268/Murine-typhus:-an-important-consideration-for-the-nonspecific-febrile-illness
- Blanton LS, Walker DH, Bouyer DH. Rickettsiae and ehrlichiae within a city park: is the urban dweller at risk? Vector Borne Zoonotic Dis. 2014;14:168–70.
- Marrero M, Raoult D. Centrifugation-shell vial technique for rapid detection of Mediterranean spotted fever rickettsia in blood culture. Am J Trop Med Hyg. 1989;40:197–9 .
- Philip RN, Casper EA, Ormsbee RA, Peacock MG, Burgdorfer W. Microimmunofluorescence test for the serological study of Rocky Mountain spotted fever and typhus. J Clin Microbiol. 1976;3:51–61 .
- Webb L, Carl M, Malloy DC, Dasch GA, Azad AF. Detection of murine typhus infection in fleas by using the polymerase chain reaction. J Clin Microbiol. 1990;28:530–4 .
- Regnery RL, Spruill CL, Plikaytis BD. Genotypic identification of rickettsiae and estimation of intraspecies sequence divergence for portions of two rickettsial genes. J Bacteriol. 1991;173:1576–89 .
- Roux V, Raoult D. Phylogenetic analysis of members of the genus Rickettsia using the gene encoding the outer-membrane protein rOmpB (ompB). Int J Syst Evol Microbiol. 2000;50:1449–55.
- Vishwanath S. Antigenic relationships among the rickettsiae of the spotted fever and typhus groups. FEMS Microbiol Lett. 1991;81:341–4.
- Older JJ. The epidemiology of murine typhus in Texas, 1969. JAMA. 1970;214:2011–7.
- Dumler JS, Taylor JP, Walker DH. Clinical and laboratory features of murine typhus in south Texas, 1980 through 1987. JAMA. 1991;266:1365–70.
- Hill EL, Ingraham SC II. A study of murine typhus fever in Coffee County, Alabama. Public Health Rep. 1947;62:875–81.
- Eremeeva ME, Karpathy SE, Krueger L, Hayes EK, Williams AM, Zaldivar Y, Two pathogens and one disease: detection and identification of flea-borne rickettsiae in areas endemic for murine typhus in California. J Med Entomol. 2012;49:1485–94.
- Adjemian J, Parks S, McElroy K, Campbell J, Eremeeva ME, Nicholson WL, Murine typhus in Austin, Texas, USA, 2008. Emerg Infect Dis. 2010;16:412–7.
TablesCite This Article
- Page created: February 18, 2015
- Page last updated: February 18, 2015
- Page last reviewed: February 18, 2015
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)